Coherent earnings up next: Can AI optics boom sustain margins?

Coherent is expected to report fiscal Q3 EPS of $1.39 on revenue of $1.78 billion, up 7.8% and 5.3% sequentially and 18.67% year over year, respectively. Demand tied to AI infrastructure remains strong, with management planning to double indium phosphide capacity in 2026 after a $2 billion NVIDIA-backed investment. Investors will focus on execution, CPO revenue timing, and whether margins can still reach the targeted 42% non-GAAP operating margin.

Analysis

COHR remains one of the cleaner second-order beneficiaries of the AI capex cycle, but the market is starting to price it as a strategic capacity bottleneck rather than a simple component supplier. That matters because bottlenecks usually attract incremental capital and new entrants, which can extend demand visibility while compressing long-run margins. The most important near-term read-through is not the headline beat/miss, but whether management can keep supply growth ahead of hyperscaler demand without sacrificing mix.

The equity setup looks asymmetric into the print because expectations have become self-contradictory: the stock is trading above the street target while the sell-side is raising long-dated targets, implying the market is already discounting the next several capacity expansions. That creates a narrow path to upside—management needs to show acceleration in utilization, lead times, or design wins; otherwise the stock can de-rate quickly on any hint that margin expansion is lagging revenue growth. The risk is that investors extrapolate infrastructure scarcity into 2026/2027, while the actual ramp may be gated by integration complexity and customer qualification cycles.

NVDA is the key hidden stakeholder here. If the capital support is real and tied to future output, it strengthens NVDA’s ecosystem control and reduces the probability of a durable component shortage, which is mildly negative for pricing power but positive for broader AI buildout duration. The contrarian read is that the market may be underestimating competitive intensity in the co-packaged optics supply chain: once the architecture shifts, customer concentration and qualification leverage increase, but so does the odds that multiple suppliers get pulled in, capping ultimate economics for any single vendor.

Key Decisions for Investors

• Stay tactically long COHR only into the print if positioning is light; target a post-earnings move driven by capacity commentary, but cut quickly if gross margin or operating margin guidance does not inflect. Risk/reward is best for a 1-2 week trade, not a multi-quarter hold, because the stock already trades above consensus valuation.
• Use a call spread in COHR for upside exposure into the catalyst rather than stock: buy near-dated calls and sell a higher strike to finance theta. This captures a positive surprise on design-win or capacity commentary while limiting downside if the market sells the print on margin fears.
• Pair long COHR / short a basket of slower-moving optical peers if you want to express relative capacity execution. The thesis is that the market will reward whichever supplier can prove the fastest qualification-to-revenue conversion over the next 2 quarters.
• Add NVDA as a hedged ecosystem beneficiary on any post-earnings weakness in COHR. If the market interprets the investment as demand validation rather than margin dilution, NVDA gains the cleaner version of the same narrative with less execution risk.
• If management hints that 2026 ramp is slipping or that operating margin targets are being pushed out, fade COHR on a 1-3 month horizon. The stock is vulnerable to multiple compression because current pricing already reflects a best-case AI infrastructure scenario.